Specify a stock or a cryptocurrency in the search bar to get a summary
Pmv Pharmaceuticals Inc
PMVPPMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. It's lead product candidate is PC14586, a small molecule that corrects mutant p53 protein containing the Y220C mutation and restores wild-type p53 function. The company was formerly known as PJ Pharmaceuticals, Inc. and changed its name to PMV Pharmaceuticals, Inc. in July 2013. PMV Pharmaceuticals, Inc. was incorporated in 2013 and is based in Princeton, New Jersey. Address: 1 Research Way, Princeton, NJ, United States, 08540
Analytics
WallStreet Target Price
7.83 USDP/E ratio
–Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures PMVP
Dividend Analytics PMVP
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History PMVP
Stock Valuation PMVP
Financials PMVP
Results | 2019 | Dynamics |